Recent studies reported that DNA methylation was involved in retinal cell death. Methyl-CpG binding domain protein 2 (Mbd2) is one of the DNA methylation readers. Its role and mechanism of regulation remain unclear. The ischemia/reperfusion (I/R) model in mice primary culture retinal ganglion cells (RGCs) and Mbd2 knockout (Mbd2-KO) mice was used in the current study. We demonstrated that Mbd2 mediates RGC apoptosis caused by I/R injury. Mechanistically, the data suggested that Mbd2 upregulated Mbd2-associated long noncoding RNA 1 (Mbd2-AL1) via demethylation of its promoter. Furthermore, Mbd2-AL1 sponged microRNA (miR)-188-3p, thus preventing tumor necrosis factor (TNF) receptor-associated factor 3 (Traf3) downregulation and inducing RGC apoptosis. This was further demonstrated by the fact that inhibition of miR-188-3p diminished the anti-apoptosis role of Mbd2-AL1 small interfering RNA (siRNA). Finally, it showed that the apoptosis of retinal cells was attenuated, and the visual function was preserved in Mbd2-KO mice, which were associated with the Mbd2-AL1/miR-188-3p/Traf3 axis. Our present study revealed the role of Mbd2 in RGC apoptosis, which may provide a novel therapeutic strategy for retinal ischemic diseases.
INTRODUCTION
Retinal ischemia/reperfusion (I/R) injury is a common cause of irreversible visual impairment that is associated with glaucoma, diabetic retinopathy, and retinal vascular occlusive disorders, 1,2 and leads to blindness, affecting over 100 million individuals in the world. The key reason is the lack of a relatively effective treatment. Previous studies demonstrated that the apoptosis of retinal ganglion cells (RGCs) caused by the endoplasmic reticulum, oxidative stress, and mitochondrial dysfunction played a pivotal role in retinal ischemia injury. [3] [4] [5] Interestingly, recent studies have reported that DNA methylation, one of the main mechanisms of epigenetic modification, was involved in the regulation of gene transcription in various diseases, including retinal cell death. [6] [7] [8] [9] [10] Methyl-CpG binding domain protein 2 (Mbd2), a key member of methyl-CpG-binding domain proteins (MBDs), plays an essential role in DNA methylation. 7, 11 Furthermore, two studies suggested the involvement of Mbd2 in apoptosis of muscle cells caused by ischemic injury 12 and in apoptosis of renal cells that are induced by vancomycin. 10 So far, the role and molecular mechanism of Mbd2 in RGC apoptosis following retinal I/R injury remain unclear.
Recently, long noncoding RNAs (lncRNAs) that are nonprotein-coding transcripts containing more than 200 nucleotides have been shown to mediate several biological processes, such as cell differentiation, metastasis, proliferation, and apoptosis. [13] [14] [15] Furthermore, lncRNAs play important roles in human disorders, including stressed RGCs. 16 MicroRNAs (miRNAs) have also been shown to regulate proliferation and apoptosis. 17 Usually, lncRNA-miRNA interactions were considered as competing endogenous RNAs (ceRNAs) that regulate the expression of target genes. 18, 19 Although previous studies have suggested the direct involvement of Mbd2 in the regulation of miRNAs, 10 it is unclear whether Mbd2 mediates I/R-induced RGC apoptosis via its interaction with lncRNAs.
In the current study, we demonstrate that Mbd2 plays a key role in RGC apoptosis that is caused by I/R injury. Mechanistically, Mbd2 can directly upregulate Mbd2-associated lncRNA 1 (Mbd2-AL1), which acts as a ceRNA, by directly binding to miRNA (miR)-188-3p and contributing in the downregulation of tumor necrosis factor (TNF) receptor-associated factor 3 (Traf3) expression during ischemic stress. Finally, our data reveal that in Mbd2-knockout (KO) mice, the I/R-induced RGC apoptosis is attenuated via a mechanism involving a targeted Mbd2-AL1/miR-188-3p/Traf3 axis. In this research, we determined the role of Mbd2 and its regulatory mechanism and further uncovered the pathology of RGC apoptosis in retinal ischemia.
RESULTS

The Expression of Mbd2 Is Induced by I/R in RGCs and Mice Retina
We first developed ischemia models, in vitro and in vivo, to detect the expression of Mbd2. Immunoblotting results indicated that Mbd2 was upregulated within the 2-h reperfusion and gradually reached a peak level at 2 h, and that was followed by a decline to base level at 4 h in primary RGCs ( Figures 1A and 1B ). Consistently, Mbd2 was also gradually upregulated 6 h after reperfusion and achieved a 24-h peak level in mice retina ( Figures 1C and 1D ). Immunofluorescent analysis further demonstrated that Mbd2 was expressed in the inner-neural retina after ischemic injury, especially in RGC nuclei (Figures 1E and 1F) . Collectively, these results suggest that I/R injury can induce the expression of Mbd2 in vitro and in vivo.
Mbd2 Mediates RGC Apoptosis Caused by I/R Injury
To determine the potential role of Mbd2 in RGC apoptosis induced by ischemia injury, Mbd2 small interfering RNA (siRNA) or Mbd2 treated with or without Ca 2+ (2 mM) and antimycin (10 mM) in HBSS (ATP and glucose depletion) at indicated time periods (ischemia/ reperfusion for 0/0 h, 2/0 h, 2/2 h, and 2/4 h, respectively). Mbd2 levels were analyzed by western blotting. I/R induces an increase of Mbd2 levels in mice RGCs. The data are shown as mean ± SEM of five independent experiments. #p < 0.05 versus the 0/0 group. (C and D) The intraocular pressure was elevated to 120 mmHg for 1 h to induce a transient retinal ischemia and then exposed to reperfusion for 6 h, 12 h, and 24 h in C57BL/6 mice, respectively. The level of Mbd2 expression gradually increased in the retinas following ischemic reperfusion injury. Immunoblot signals were quantified by densitometry and normalized to the internal control b-tubulin. The data are shown as mean ± SEM of five independent experiments. #p < 0.05 versus the 0/0 group. (E and F) Immunofluorescent staining of retinal sections from 24-h reperfusion and after 1 h ischemia compared with control animals. The green signal represents the subcellular localization of Mbd2 in nucleus. The number of Mbd2-positive cells in the RGC layer was significantly higher than in the sham group (yellow arrowheads (Table  S1) , whereas downregulated 315 genes in the Mbd2-siRNA group (Table S2) . Interestingly, 13 of the 315 downregulated lncRNA promoter regions exhibited the CpG island with the highest upregulation fold changes ( Figure 3B ). Among them, ENSMUST00000160470 and ENSMUST00000123262 ranked first and second, respectively. Quantitative real-time PCR supported The level of Mbd2 and cleaved caspase3 was significantly increased when RGCs were transfected with Mbd2 plasmid. Data were expressed as mean ± SEM of five independent experiments. #p < 0.05 versus the scramble group; *p < 0.05 versus the scramble/I/R group.
the findings obtained from the lncRNA chip experiment ( Figure 3C ) and further indicated that reperfusion induced the expression of ENSMUST00000160470 at indicated time points and reached the peak at 2 h after reperfusion ( Figure 3D ). The data indicate that lncRNA ENSMUST00000160470 (Mbd2-AL1) may be a target of Mbd2.
Mbd2 Suppresses Promoter Methylation of Mbd2-AL1 and Activates Its Demethylation
Although Mbd2 mediated the expression of Mbd2-AL1, the mechanism of regulation remains unclear. To investigate this, we performed a CpG island prediction analysis and primers design in silico (MethPrimer 2.0 software) ( Figure 4A ). Among five pair primers, only mBS4 was identified as a potential Mbd2 binding site in the Mbd2-AL1 promoter region and assessed by the chromatin immunoprecipitation (ChIP) assay ( Figure 4B ). The methylated cytosine and guanine (CG) DNA of the Mbd2-AL1 promoter was cloned into the pCpGfree-basic-Lucia (pCpGl) plasmid and cotransfected with Mbd2 or mutational Mbd2 (mtMbd2; depletion of DNA methylation domain) plasmids. The transcription activity was enhanced by Mbd2 overexpression but not mtMbd2 ( Figure 4C ). Furthermore, methylation level analysis indicated that methylated pCpGl of Mbd2-AL1 was inhibited by the endogenous Mbd2, and the effect was reinforced by ectopic Mbd2 expression ( Figure 4D ). Thus, Mbd2 siRNA suppressed the expression of Mbd2-AL1, and this could be reversed by overexpressing Mbd2 (Figures 4E and  4F ). Taken together, Mbd2 binds to the promoter region of Mbd2-AL1 and is associated with its demethylation.
Mbd2-AL1 Mediates I/R-Induced RGCs Apoptosis
To further verify the role of Mbd2-AL1 in the RGC apoptosis induced by I/R, Mbd2-AL1 siRNA or Mbd2-AL1 plasmids were transfected into RGCs and were subjected to ischemic treatment. 2 h after reperfusion, the FCM analysis indicated that RGC apoptosis was attenuated by Mbd2-AL1 siRNA ( Figures 5A and 5B ). By contrast, the effect was enhanced by Mbd2-AL1 overexpression ( Figures 5G and 5H ). The quantitative real-time PCR results indicated that the expression of Mbd2-AL1, induced by I/R, was suppressed by Mbd2-AL1 siRNA (Figure 5C); however, this effect was enhanced with the Mbd2-AL1 plasmid ( Figure 5I ). Consistently, the immunoblotting results also demonstrated an activation of caspase3, and that was inhibited by Mbd2-AL1 siRNA ( Figures 5D-5F ). However, the effect was increased with the Mbd2-AL1 plasmid ( Figures 5J-5L ). Collectively, the data suggest that Mbd2-AL1 is an apoptosis inducer during ischemia injury.
miR-188-3p Is a Direct Target of lncRNA Mbd2-AL1
A previous study suggested that lncRNAs act as a "sponge" through their association with miRNAs and to regulate target gene expression. 20 We predicted that Mbd2-AL1 exhibited complementary sequences to miR-188-3p using the in silico RegRNA software. The sequences of complementary and mutated Mbd2-AL1 (Mbd2-AL1 wild type [WT] and Mbd2-AL1 mutant [MUT], respectively) were cloned into a luciferase reporter plasmid, respectively ( Figures 6A and 6B ). The results indicated that the miR-188-3p mimic suppressed the luciferase activity of Mbd2-AL1 WT, instead of the Mbd2-AL1 MUT ( Figure 6B ). Furthermore, the expression of miR-188-3p was enhanced by Mbd2-AL1 siRNA. In contrast, the effect was reversed by Mbd2-AL1 overexpression ( Figures 6C and 6D) . Besides, the fluorescence in situ hybridization (FISH) array experiment indicated that Mbd2-AL1 and miR-188-3p colocalized in RGC cytoplasm of the control group and that these effects were enhanced by I/R treatment ( Figure 6E ). These findings suggest that Mbd2-AL1 has a sponging effect on miR-188-3p in RGCs. 
I/R-Induced RGC Apoptosis Is Suppressed by the Overexpression of miR-188-3p
A previous study has reported that miR-188-3p inhibits apoptosis of spermatogenic cells. 21 It is still unclear whether miR-188-3p has the same function in I/R-induced apoptosis of RGCs. Two hours after reperfusion, FCM analysis indicated that the miR-188-3p mimic markedly suppressed I/R-induced RGC apoptosis (Figures 7A and 7B). Quantitative real-time PCR analysis indicated that the expression of miR-188-3p was suppressed by I/R treatment, which was reversed by the miR-188-3p mimic ( Figure 7C ). Finally, the miR-188-3p mimic significantly suppressed the activation of caspase3 ( Figures 7D-7F ). These results reveal that miR-188-3p suppresses I/R-induced RGC apoptosis.
The Apoptosis Inducer Traf3 Is a Target Gene of miR-188-3p
One study reported that the TNF receptor-associated factor 3 (Traf3) protein is an apoptosis inducer in malignant human urothelial cells. 22 The prediction result indicates that Traf3 is a target gene of miR-188-3p using the miRbase analysis website (Figure 8A) . The luciferase activity of Traf3-WT, instead of Traf3-MUT, was suppressed by the miR-188-3p mimic ( Figure 8B ). We further explored the role of miR-188-3p in Mbd2-AL1-mediated, I/R-induced RGC apoptosis. To this end, we tested whether the knockdown of miR-188-3p reverses the apoptotic effect of Mbd2-AL1 siRNA. FCM analysis showed that Mbd2-AL1 siRNA mitigated RGC apoptosis; in contrast, the effect was reversed by the miR-188-3p inhibitor ( Figures 9A and 9B ). By quantitative real-time PCR, the levels of Mbd2-AL1 and miR-188-3p were detected following transfection ( Figures 9C and 9D ). In the meantime, the levels of Traf3 and cleaved caspase3 that were induced by I/R were suppressed by Mbd2-AL1 siRNA but abrogated by the miR-188-3p inhibitor ( Figures 9E-9H ). Collectively, these data demonstrate that Mbd2-AL1 mediates I/R-induced RGC apoptosis by targeting miR-188-3p.
Deletion of Mbd2 Ameliorates RGC Apoptosis and Preserves Retinal Function Following I/R Injury
To further determine the effects of Mbd2 in ischemia-induced RGC apoptosis in vivo, we quantified RGCs by specific Tuj1 (neuronal class III b-tubulin) staining and terminal-deoxy-transferase-mediated 2 0 -deoxyuridine, 5 0 -triphosphate (dUTP) nick end-labeling (TUNEL) staining and evaluated retinal function in Mbd2 knockout mice following I/R injury. Compared with the Mbd2-WT mice at 7 days following I/R stress (1,100 ± 240 RGC/mm 2 ), mice lacking Mbd2 showed significantly higher levels of RGC survival (2,400 ± 140 RGC/mm 2 ); however, RGC survival remained lower than those in sham controls (3,610 ± 220 RGC/mm 2 ) ( Figures 10A and 10B ). 24 h after reperfusion, the TUNEL-positive staining was significantly decreased in Mbd2-KO mice retinas compared with Mbd2-WT mice retinas ( Figures 10C and 10D ). Along with our morphological results, we also performed a scotopic electroretinogram (ERG) to evaluate changes in retinal function of Mbd2-WT and Mbd2-KO mice, 2 and 7 days after reperfusion. We noticed significantly decreased bwave amplitudes in all mice ( Figures 10E and 10F ). However, Mbd2-KO eyes displayed statistically significant recoveries at these two time points when compared with WT mice eyes. In summary, these results confirm that the deletion of Mbd2 ameliorates RGC apoptosis and delays loss of visual function following I/R injury in vivo. Since Mbd2 silencing protects I/R-induced RGC apoptosis in mice retina, we aimed to confirm the molecular mechanism in vivo. Quantitative real-time PCR analysis showed an upregulation of lncRNA Mbd2-AL1 in retina of the I/R model, which was decreased when Mbd2 was knocked out ( Figure 11A ). As expected, miR-188-3p was decreased by I/R and recovered in Mbd2-KO mice ( Figure 11B ). Moreover, immunoblotting showed that the expression of Mbd2, Traf3, and cleaved caspase3 was elevated in ischemic retina; however, Mbd2 deletion can significantly suppress the expression of apoptosis-related genes ( Figures 11C and 11D) . The data demonstrate that Mbd2 mediated I/R-induced RGC apoptosis in mice retina via the lncRNA Mbd2-AL1/miR-188-3P/Traf3 axis ( Figure 12 ).
DISCUSSION
Previous studies have demonstrated that DNA methylation was involved in retinal cell death. 23, 24 In the current study, we demonstrate, for the first time, that the DNA methylation reader Mbd2 mediates I/R-induced RGC apoptosis in primary RGCs. Mechanistically, Mbd2 upregulated the expression of lncRNA Mbd2-AL1 via the A previous study demonstrated that Mbd2 mediated ischemic injury in mice hindlimb. 12 A recent study revealed that Mbd2 was induced and promoted the upregulation of the glucocorticoid receptor in the hippocampus of maternal nurturing in mice. 25 So far, the role of Mbd2 in RGCs remains unclear. In the present study, we found that Mbd2 was localized in RGC nuclei and induced by I/R injury in vitro and in vivo. Furthermore, I/R-induced RGC apoptosis was attenuated by Mbd2 siRNA and enhanced by its overexpression. Finally, Mbd2-KO mice had a markedly decreased I/R-induced RGC apoptosis and improved visual functions. Thus, our data suggest that Mbd2 mediates RGC apoptosis following I/R injury.
In this study, we report for the first time that Mbd2 could regulate the expression of lncRNA to mediate RGC apoptosis following I/R injury. A recent study has reported that Mbd2 upregulates miR-301a-5p to mediate renal cell apoptosis during vancomycin treatment. 10 Although many studies reported that lncRNAs were involved in the progression of retinal diseases, [26] [27] [28] it is still unclear whether Mbd2 regulates the expression of lncRNAs. Here, we found that lncRNA Mbd2-AL1 was a direct target of Mbd2, as suggested by our results. First, the results of microarray analysis and quantitative real-time PCR indicated that Mbd2 siRNA notably suppressed the I/R-induced expression of lncRNA Mbd2-AL1; however, this effect was reversed by Mbd2 overexpression. Second, we found that Mbd2 upregulated the expression of Mbd2-AL1 via the demethylation of the promoter of Mbd2-AL1. Finally, Mbd2-KO mice had attenuated I/R-induced expression of lncRNA Mbd2-AL1. Collectively, these data show that Mbd2 directly regulates the expression of lncRNA Mbd2-AL1.
Recent studies reported that lncRNAs GAS5 and Sox2OT promoted the apoptosis of RGCs, 29, 30 whereas lncRNA MALAT1 suppressed this effect. 31 Our data demonstrated that lncRNA Mbd2-AL1 mediated I/Rinduced RGC apoptosis. As we know, lncRNA acted as a ceRNA to sponge miRNA. [32] [33] [34] For example, lncRNA antisense noncoding RNA in the INK4 locus (ANRIL) serves as a competing endogenous RNA to sponge miR-99a and promote apoptosis in retinoblastoma Y79 cells. 35 Hence, we predicted that miR-188-3p was a target gene of lncRNA Mbd2-AL1. Several experiments were performed to demonstrate this hypothesis. First, following I/R injury, the suppression of miR-188-3p was enhanced by the overexpression of Mbd2-AL1; however, this effect was reversed by Mbd2-AL1 siRNA. Second, the FISH results indicated that Mbd2-AL1 and miR-188-3p colocalized in the cytoplasm of RGCs. Finally, the luciferase reporter assay further confirmed their interaction. In addition, the role of miR-188-3p in cell apoptosis remains controversial. One study demonstrated that miR-188-3p suppressed the apoptosis of spermatogenic cells. 21 However, another study reported that miR-188-3p promoted neuroapoptosis and cognitive impairments in animals. 36 In the current study, we found that miR-188-3p inhibits RGC apoptosis induced by I/R injury. To further clarify the anti-apoptosis mechanism of miR-188-3p, we focused on an apoptosis inducer of Traf3. 22 First, we predicted that Traf3 was the target of miR-188-3p. Subsequently, the luciferase reporter assay confirmed that miR-188-3p directly binds to the 3 0 UTR region of Traf3. In addition, the overexpression of miR-188-3p suppressed Traf3 mRNA and protein expression levels and later mediated RGC apoptosis during I/R injury. Finally, the miR-188-3p inhibitor reversed the anti-apoptosis effect of Mbd2-AL1 siRNA following ischemic injury. Interestingly, Mbd2-KO mice significantly suppressed the Mbd2-AL1/miR-188-3p/Traf3 axis. Taken together, these results demonstrated that the Mbd2/Mbd2-AL1/miR-188-3p/Traf3 axis was responsible for RGC apoptosis during I/R injury.
In summary, our data demonstrated that Mbd2 mediated I/Rinduced RGC apoptosis in primary RGCs and mice. Mechanistically, Mbd2 promoted the expression of lncRNA Mbd2-AL1 through promoter hypomethylation, leading to the inhibition of miR-188-3p expression, which prevented Traf3 downregulation. Taken together, the data suggest that Mbd2 may be a pivotal therapeutic target in retinal ischemic reperfusion injury.
MATERIALS AND METHODS
Ethics Statement
Mbd2 global knockout mice were purchased from Cyagen Biosciences (Guangzhou, People's Republic of China). All of the experiments were carried out in accordance with a protocol approved by the Animal Care and Use Committee of the Second Xiangya Hospital, Central South University in China.
Animals
Mice were housed under a 12:12-h light/dark cycle and were allowed free access to water and food. C57BL/6J mice (Jackson Laboratory) were used as wide-type (WT) controls. Experimental interventions were conducted under anesthesia using intraperitoneally injected solution of ketamine (100 mg/kg body weight; Ratiopharm, Ulm, Germany) and xylazine (5 mg/kg; Bayer Vital, Leverkusen, Germany). All animals were directly and daily observed after each intervention to ensure adequate health conditions and general behaviors.
Ischemia/Reperfusion Model
Mice were anesthetized as described above. Corneal analgesia was achieved with topical drops of 0.4% oxybuprocaine hydrochloride (Santen Pharmaceutical, Japan). Retinal I/R injuries were carefully established by cannulation of the cornea in the right eyes with a 33-gauge infusion needle that was connected to a plastic container of 200 mL sterile saline solution (0.9%) and as was described in previous methods. 5, 37 The intraocular pressure was raised to 120 mmHg (measured with the TonoLab) for 60 min by elevating the saline container, followed by reperfusion in mice. The contralateral eye was cannulated and maintained at normal intraocular pressure to serve as a control. Retinal ischemia was confirmed by whitening of the iris and loss of red reflex and subsequent reperfusion by the return of the red reflex. During the experiment, the body temperature was maintained on a temperature-controlled heat pad at 37 C. After needle removal, 0.3% tobramycin and 0.1% dexamethasone eye ointment (Alcon Cusi, Spain) were applied to the conjunctival sac. The mice were killed by CO 2 inhalation under anesthesia. Animal experiments were performed in accordance with a protocol approved by the Institutional Committee for the Care and Use of Laboratory Animals of the Second Xiangya Hospital, China.
Isolation and Culture of RGCs
Primary RGCs were isolated from the retina of 1-to 4-day postnatal newborn mice of either sex, as reported in previous studies, but with a partial modification. 16, 38 All procedures were carried out under aseptic conditions. The day before dissection of the retina, we prepared a polyd-lysine (Sigma; P6407)-and laminin (Sigma; L-6274)-coated 24-well plate; purified donkey anti-rabbit immunoglobulin G (IgG; heavy-chain [H] and light-chain [L])-coated, 75-cm 2 cell-culture dish for antimacrophage panning; and donkey anti-rat IgG (H and L)-coated, 100-cm 2 dish for Thy1.2 antibody. An amount of 5 mL Dulbecco's PBS (DPBS) containing 30 mL Thy1.2 antibody (Sigma; M7898) was added to a 100-cm 2 dish before use. The retinas were washed in DPBS using a pipette and transferred to a papain solution for incubation at 37 C for 15 min. Low ovomucoid plus rabbit anti-mouse microphage antibody was added and incubated for 5 min at room temperature (RT) for macrophage binding. A panning buffer was added to bring up the volume, and the cell suspension was removed to the previously prepared antimacrophage flask and incubated for 40 min at RT. The flask was gently shaken, and the cells were filtered through a Nitex mesh into an autoclaved beaker. The cell suspension was transferred to a Thy1.2 dish for 1 h, nonadherent cells were discarded, and 4 mL trypsin/Earle's balanced salt solution (EBSS) was added to digest RGCs off the plate. An amount of 80 mL was removed for cell counting and viability assessment, and the rest of the solution was centrifuged at 200 g for 5 min. The cell pellet was resuspended in pre-equilibrated RGC growth media. Laminin was removed from the poly-D-lysine-coated culture dish, and the cells were added with culture medium. RGCs were cultured in moist air with 5% of CO 2 and 95% O 2 at 37 C. 50% of medium was removed and replaced with prewarmed whole-growth medium every 3 days. (More details of reagents can be seen in the Supplemental Information.)
Cell viability was determined with a cytotoxicity staining kit (Live/ Dead; Molecular Probes). The live cells cleaved calcein, yielding green fluorescence; the nucleic acids of the dead cells were labeled with red fluorescence using ethidium D. The cells were counted with the inverted microscope Leica DMI3000B, equipped with fluorescence illumination.
In Vitro Ischemia Simulation and Transfection of RGCs
The ischemic model of RGCs was made according to the previously published study. 39 Briefly, as RGCs were over 90 percent confluent, the media were changed to Hanks' balanced salt solution (HBSS), with 10 mM antimycin A (a complex III inhibitor of mitochondrial electron transport; ab141904; Abcam, Cambridge, MA, US) and 2 mM calcium ionophore (A2318; Aladdin, Shanghai, China), which were dissolved in dimethylsulfoxide (DMSO) for 2 h. The wholegrowth medium was retrieved and sustained for 0 h to 4 h. Lipofectamine 2000 was applied for the transfection of 50 nM of Mbd2 siRNA, Mbd2-AL1 siRNA, Traf3 siRNA, plasmid of Mbd2, Mbd2-AL1, and miR-188-3p mimic or inhibitor (Ribobio, Guangzhou, China), 24 h before ischemia treatment and following the manufacturer's instruction.
Flow Cytometry Analysis of Apoptosis
Cell apoptosis was detected using the Annexin V/propidium iodide (PI) staining kit. Fluorescein isothiocyanate (FITC; #556547) and phycoerythrin (PE; #559763) Annexin V Apoptosis Detection Kit I was purchased from BD Biosciences (Franklin Lake, NJ, US). RGCs were trypsinized with 0.25% trypsin and washed twice with cold PBS and then resuspended in one time binding buffer at a concentration of 1 Â 10 6 cells/mL. 100 mL from the above solution was transferred to a 5-mL culture tube, and 5 mL FITC Annexin V (or PE Annexin V) and 5 mL PI (or 7-aminoactinomycin D [7-AAD]) were added. The cells were gently vortexed and incubated for 15 min at RT (25 C) and in the dark. A 400-mL one time binding buffer was added to each tube. Flow cytometry was conducted, and the data were analyzed using FACSCalibur and FlowJo V10 software within 1 h.
Western Blotting
Retina tissues and cells were lysed using a lysis buffer (125 mM HCl [pH 6.8], 4% SDS, 20% glycerol, urea 0.36 g/mL, 20 mM DTT, 1% proteinase inhibitor cocktail), and the proteins were resuspended in SDS-PAGE loading buffer. Equal amounts of samples were loaded in each lane. The proteins were separated in 12% polyacrylamide gels and transferred to polyvinylidene difluoride (PVDF) membranes. The blots were then probed with primary antibodies against Mbd2 (Gen-Bank: 17191) (#ab188474; Abcam, Cambridge, MA, US), caspase3/ cleaved caspase3 (#9662; CST, Danvers, MA, US), Traf3 (GenBank: 22031) (#ab36988; Abcam), and b-tubulin (#10094-1-AP; Proteintech, Rosemont, IL, US), followed by incubation with species-specific horseradish peroxidase-conjugated secondary antibodies (goat antirabbit IgG, SA00001-2; Proteintech), and visualized by enhanced chemiluminescence (Millipore; WBKLSO500). Finally, the images were captured by Tanon 5200 Multi. The target proteins were quantified by Photoshop software and normalized by internal control b-tubulin to get relative expression levels.
Quantitative Real-Time PCR
Total RNA from retinas and RGCs were extracted using Trizol reagent (Invitrogen, Carlsbad, CA, US), according to the manufacturer's protocol. Approximately 40 ng total RNA was reverse transcribed using the PrimeScript RT Reagent Kit and genomic DNA (gDNA) Eraser Kit (RR047A; Takara, Dalian, Liaoning, China). The expression levels of lncRNAs, miRNAs, and mRNAs were detected using SYBR Green (#K0221; Thermo Scientific, Waltham, MA, US), and the DCt value was calculated and obtained using StepOne software (Bio-Rad, Hercules, CA, US). The sequences of lncRNA Mbd2-AL1 and miR-188-3p were retrieved from GenBank database (GenBank: 67895 and GenBank: 387183, respectively). Primer sequences were included in Table S3 .
ChIP Analysis
The Chromatin Immunoprecipitation Kit (#17-371RF; Millipore, MA, US) was used to analyze the interaction between Mbd2 and relevant lncRNAs following the manufacturer's instructions. In brief, 37% formaldehyde (or fresh 18.5% formaldehyde) was added into the cell growth media to cross link the proteins to the DNA. Then, the cells were lysed and sonicated to obtain 200 bp-to 1,000 bp-length crosslinked DNA. Anti-Mbd2 antibody was used to pull down the immunoprecipitate (IP) of crosslinked protein/ DNA at 4 C, incubating overnight. 60 mL of protein G agarose was added to each IP and incubated for 1 h at 4 C, with rotation to collect the antibody/antigen/DNA complex. Afterward, protein/ DNA complexes were eluted, and the crosslinks reversed between protein/DNA complexes to free DNA. Finally, a spin column was used to bind free DNA onto filter paper discs for DNA purification. The precipitated DNAs were detected by PCR using specific mBS1-5 primers (Table S3 ).
Luciferase Reporter Assay
The Dual-Luciferase Reporter Assay System Kit (E1910) was purchased from Promega (Madison, WI, US). On one hand, we constructed pCpGfree-basic-Lucia (pCpGl) reporter (Invivogen, San Diego, CA, US; #pcpgf-basic) that contained CG DNA methylation target sequences in the promoter region of lncRNA Mbd2-AL1, which was cotransfected with Mbd2 or mtMbd2 (mutational Mbd2, depletion of DNA methylation domain) plasmids and the renilla plasmid. On the other hand, dual-luciferase reporter (firefly luciferase-renilla luciferase double labeled) of lncRNA Mbd2-AL1-WT or -MUT and Traf3-WT or -MUT (mutation) at 3 0 UTR regions was constructed and cotransfected with the miR-188-3p mimic, and the cells were lysed by passive lysis buffer, 48 h later. Luciferase Assay Reagent II (LAR II) was added and the firefly luciferase levels detected. Stop & Glo Reagent (substrate + buffer) to measure the renilla luciferase values was added. Finally, luciferase levels were normalized by renilla luciferase values to obtain final results. The plasmids above were constructed by RuQi Biotechnology (Guangzhou, Guangdong, China).
Fluorescence In Situ Hybridization (FISH)
For FISH analysis, the Fluorescent In Situ Hybridization Kit (C10910; Ribobio, Guangzhou, China) was used. Briefly, RGCs were fixed in paraformaldehyde and hybridized overnight at 37 C with miR-188-3p and lncRNA Mbd2-AL1 probes (Ribobio, Guangzhou, China) in hybridization buffer, and the cell nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI). Fluorescence images were captured using a laser-scanning confocal microscope (Nikon; Eclipse Ti), and the images were conducted by Eclipse C2 (Nikon, Tokyo, Japan).
Immunofluorescence and TUNEL Assay
Following I/R injury, the mice were sacrificed at time intervals of 6 h, 12 h, 24 h, 48 h, and 7 days. The eyes were immediately enucleated, treated with 4% paraformaldehyde for 1 h, and the anterior section was removed. Then, the eye cups were put in FAS eye-fixation buffer (Servicebio; G1109) at 4 C overnight and dehydrated in 30% source solution. Eye cups were embedded in OCT (optimum cutting temperature compound) and frozen at À80 C. 10 mm-thick cryosections of eye cups were obtained by a freezing microtome. All of the sections were permeabilized and blocked (10% BSA, 0.1% Triton X-100 in PBS) for 1 h. Eye sections were incubated with primary antibodies at 4 C overnight, followed by 2 h incubations at RT in the dark with the secondary antibodies CY3-goat anti-rabbit IgG (BA1032; Boster, Wuhan, China) and goat anti-rabbit IgG H and L (Alexa Fluor 488, ab150077; Abcam). The nuclei were visualized with DAPI. Retina whole mount was treated as before, but in this case, the retinas, instead of the eye cups, were dissected. The retinas were permeabilized with a higher concentration of Triton X-100 at 10%, and a terminal-deoxy-transferase-mediated 2 0 -deoxyuridine, 5 0 -triphosphate (dUTP) nick end-labeling (TUNEL) (#1684795; Roche, Basel, Switzerland) assay was performed, according to the manufacturer's instructions, to detect apoptotic RGCs in the retinas. Briefly, cryosections were permeabilized and incubated with TUNEL solution (including 50 mL enzyme solution [terminal deoxynucleotidyl transferase (TdT)] and 450 mL label solution [fluorescein-dUTP]) at 37 C for 1 h and then washed with PBS and stained with DAPI.
Electroretinography
As it was reported that a diminished b-wave was a sensitive marker of ischemic injury, 40 we evaluated retinal function by ERG in mice. ERG was performed at 0 h, 48 h, and 7 days after ischemia. After at least 6 h of dark adaptation, the animals were anesthetized and prepared for recording, as previously described. Briefly, the animals were placed in a specially designed dome with body temperature maintained at 37 C. The corneas were anesthetized with a topical 0.4% oxybuprocaine hydrochloride, and the pupils were dilated with 1% tropicamide. Five electrodes were separately applied to the subcutaneous tissue by the tails, beneath each eye, and at the apex of the corneas of the two eyes. Each eye was exposed to light flashes at a series of intensity (0.01, 3, and 10 cd.s/m 2 ). The amplitudes and implicit times of waveforms were measured and analyzed. 41 
Statistical Analysis
All data values were expressed as mean ± standard deviations of the mean (SEM). One-way ANOVA, followed by the Tukey's post-hoc test was used to compare multiple treatment groups. Two-way ANOVA was used to assess the statistical significance of the differences between multiple treatment groups at different time points. Data were expressed as mean ± SEM of five independent experiments. The results were statistically significant when p < 0.05.
